Skip to main content

Fosun Pharmaceutical Headquarters


Company Headquarters: No. 1289, Yishan Road, Shanghai (Building A, Fosun Science Park), China
Postal Code: 200233
Phone: +86-21-33987000
Fax: +86-21-33987020

Investor Relations
Contact: Li Xinlei
Tel: +86-21-33987870
Fax: +86-21-33987871
Email: ir@fosunpharma.com

media interview
Contact person: Liu
Mingyi Tel: +86-21-33987118 (Forward transfer)
Fax: +86-21-33987020
Email: pr@fosunpharma.com

Investment Cooperation
Tel: +86-21-33987118 (forwarding at the front desk)
Email: invest@fosunpharma.com

Social responsibility
Contact: Sun Li
Tel: +86-21-33987118 (Foreign transfer)
Fax: +86-21-33987020
Email: sunl@fosunpharma.com

International Business
Tel: +86-21-33987000
Fax: +86-21-33987020
Email: int@fosunpharma.com

Human Resources (Career Opportunities and Talent Management)
Tel: +86-21-33987089
Fax: +86-21-33987020
Email: zhaopin@fosunpharma.com

Business development (new technology, new project cooperation)
Contact: Zhang Zhenshan
Tel: +86-21-33987591
Fax: +86-21-33987020
Email: zhangzhsh@fosunpharma.com

Integrity and compliance
Tel: +86-21-33987226
Fax: +86-21-33987020
Email: lianzhengdc@fosunpharma.com

Report adverse drug reactions
Contact department: Fosun Pharma Pharmacovigilance Department
Email: FSADEDESK@fosunpharma.com Adverse


Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharmaceutical” for short, stock code: 600196.SH, 02196.HK) was established in 1994 and is a leading medical and health industry group in China. Fosun Pharma’s business development is based in China and has a global presence, with pharmaceutical manufacturing and R&D as the core, covering medical devices and medical diagnosis, medical services, pharmaceutical distribution and retail.

Fosun Pharma Group takes innovative R&D as its core driving factor, continues to improve the drug R&D system of “combination of generics and innovation”, and builds an international R&D platform for small molecule innovative drugs, high-value generic drugs, biological drugs, and cell therapy.

Facing the future, under the guidance of the "4IN" (Innovation Innovation, Internationalization, Integration, and Intelligent Intelligentization) strategy, Fosun Pharma Group adheres to the brand concept of "Continuous Innovation, Enjoying Health" and is committed to becoming a global mainstream medical A leading company in the health market.

Comments